Lay J P, Ashleigh R J, Tranconi L, Ackrill P, Al-Khaffaf H
Department of Radiology, Withington Hospital, Manchester, UK.
Clin Radiol. 1998 Aug;53(8):608-11. doi: 10.1016/s0009-9260(98)80155-4.
To determine the results of transluminal angioplasty in patients with Brescia-Cimino arteriovenous fistulae.
Thirty-one patients underwent transluminal angioplasty of 36 stenotic lesions related to Brescia-Cimino arteriovenous fistulae over a 5-year period. The lesions treated were characterized by review of pre-angioplasty fistulograms. Medical and radiological records were reviewed to assess medium-term patency of each patient's fistula.
Angioplasty was performed successfully in 28 out of 31 patients initially (90% technical success rate). Duration of follow-up for the 31 patients ranged from 4 to 65 months (median = 34 months). At 6 months, seven patients required further surgical or endovascular intervention (18 patients remained event-free) and at 1 year, 10 patients required further endovascular or surgical intervention (14 patients remained event-free). Life-table analysis revealed primary patency rates of 77%, 64% and 39% at 6 months, 1 year and 2 years, respectively. At 6 months and 1 year, four and five patients, respectively, required surgical revision or closure of fistula. Secondary patency rates were 85%, 81% and 65% at 6 months, 1 year and 2 years, respectively. All patients with a primary patency at 2 years remained event-free during the follow-up period.
Transluminal angioplasty is an effective treatment for stenoses developed in relation to Brescia-Cimino haemodialysis fistulae. Further endovascular procedures may be required, especially in the first 24 months, to preserve patency. These techniques extend the lifetime of fistulae, thereby preserving proximal venous access sites for future use. Our result is in broad agreement with results from other series.
确定腔内血管成形术治疗布雷西亚-奇米诺动静脉内瘘患者的效果。
在5年期间,31例患者对36处与布雷西亚-奇米诺动静脉内瘘相关的狭窄病变进行了腔内血管成形术。通过术前内瘘造影复查来确定所治疗病变的特征。回顾医疗和放射学记录以评估每位患者内瘘的中期通畅情况。
最初31例患者中有28例成功进行了血管成形术(技术成功率为90%)。31例患者的随访时间为4至65个月(中位数 = 34个月)。6个月时,7例患者需要进一步的外科或血管内介入治疗(18例患者无事件发生);1年时,10例患者需要进一步的血管内或外科介入治疗(14例患者无事件发生)。寿命表分析显示,6个月、1年和2年时的初始通畅率分别为77%、64%和39%。6个月和1年时,分别有4例和5例患者需要进行外科修复或关闭内瘘。6个月、1年和2年时的次级通畅率分别为85%、81%和65%。所有2年时保持初始通畅的患者在随访期间均无事件发生。
腔内血管成形术是治疗与布雷西亚-奇米诺血液透析内瘘相关狭窄的有效方法。可能需要进一步的血管内治疗,尤其是在最初24个月内,以维持通畅。这些技术延长了内瘘的使用寿命,从而保留了近端静脉通路以备将来使用。我们的结果与其他系列研究的结果基本一致。